Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021.
BMC Health Serv Res
; 23(1): 903, 2023 Aug 23.
Article
em En
| MEDLINE
| ID: mdl-37612678
ABSTRACT
BACKGROUND:
Vaccination schedules differ from country to country. In France, the diphtheria, tetanus, pertussis, poliomyelitis (dTcaP) booster vaccine coverage for adults aged 25 has been lower than those recommended. We evaluated the impact of an awareness campaign undertaken by the French national health insurance system in 2021.METHODS:
A randomized, controlled study with adults residing in the Ardennes region was conducted to evaluate the effect on vaccine coverage of the booster vaccine reminder campaign carried out via letter and/or email and/or SMS. The randomization unit was the municipal administrative area (canton). Ten cantons were grouped into the intervention group (INT) and nine were the control group (CON). Outcomes were the booster vaccine delivery and the consultation of a general practitioner (GP) within 12 months (since the French national health insurance running the campaign suggested patients to consult their GP).RESULTS:
A total of 1,975 adults were included (INT 67.3% vs. CON 32.7%). Of them, 331 received a booster vaccine (INT 17.4% vs. CON 15.5%; p = 0.29), and 1,442 consulted a GP (INT 73.7% vs. CON 76.8%; p = 0.14). Those who consulted a GP had more frequent vaccine delivery (INT 19.1% vs. CON 10.5%; p < 0.0001).CONCLUSIONS:
This study found that the awareness campaign run by the French national health insurance did not improve the uptake of the dTcaP booster and that there was a low rate of vaccinated adults aged 25 years. A GP consultation was associated with dTcaP booster vaccine delivery which may show that there is a need of involving GPs in vaccination follow-ups. Patients recognize GPs as providers of credible information and they may play a key role in individualized preventive healthcare actions. Systematic consultations with GPs for follow-up could be proposed to insured adults aged 25 years in the future.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Correio Eletrônico
/
Clínicos Gerais
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Humans
País como assunto:
Europa
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article